| Title | Expert Review of Neurotherapeutics |
| Abbreviation | Expert Rev. Neurother. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Neurology (clinical) (Q1); Pharmacology (medical) (Q1); Neuroscience (miscellaneous) (Q2) |
| h-index | 103 |
| Overall Rank/Ranking | 3760 |
| SCImago Journal Rank (SJR) | 1.162 |
| Impact Score | 3.30 |
| Publisher | Taylor and Francis Ltd. |
| Country | United Kingdom |
| ISSN | 14737175, 17448360 |
| Best Quartile | Q1 |
| Coverage History | 2001-2025 |
Expert Review of Neurotherapeutics (ISSN 1473-7175) provides expert reviews on the use of drugs and medicines in clinical neurology and neuropsychiatry. Coverage includes disease management, new medicines and drugs in neurology, therapeutic indications, diagnostics, medical treatment guidelines and neurological diseases such as stroke, epilepsy, Alzheimer"s and Parkinson"s.
Comprehensive coverage in each review is complemented by the unique.
Expert Review of Neurotherapeutics is a journal covering the technologies/fields/categories related to Neurology (clinical) (Q1); Pharmacology (medical) (Q1); Neuroscience (miscellaneous) (Q2). It is published by Taylor and Francis Ltd.. The overall rank of Expert Review of Neurotherapeutics is 3760. According to SCImago Journal Rank (SJR), this journal is ranked 1.162. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 103. The best quartile for this journal is Q1.
The ISSN of Expert Review of Neurotherapeutics journal is 14737175, 17448360. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Expert Review of Neurotherapeutics is cited by a total of 1112 articles during the last 3 years (Preceding 2024).
The Impact IF 2024 of Expert Review of Neurotherapeutics is 3.30, which is computed in 2025 as per its definition. Expert Review of Neurotherapeutics IF is increased by a factor of 0.05 and approximate percentage change is 1.54% when compared to preceding year 2023, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2024 of Expert Review of Neurotherapeutics is 3.30. If the same upward trend persists, Impact IF may rise in 2025 as well.
| Year | Impact IF |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 3.30 |
| 2023 | 3.25 |
| 2022 | 3.69 |
| 2021 | 3.61 |
| 2020 | 4.00 |
| 2019 | 3.41 |
| 2018 | 3.08 |
| 2017 | 3.24 |
| 2016 | 3.15 |
| 2015 | 2.60 |
| 2014 | 2.84 |
Expert Review of Neurotherapeutics has an h-index of 103. It means 103 articles of this journal have more than 103 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Expert Review of Neurotherapeutics is 14737175, 17448360. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Expert Review of Neurotherapeutics is 3760. According to SCImago Journal Rank (SJR), this journal is ranked 1.162. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 1.162 |
| 2023 | 0.957 |
| 2022 | 0.995 |
| 2021 | 1.020 |
| 2020 | 1.187 |
| 2019 | 1.101 |
| 2018 | 1.064 |
| 2017 | 1.006 |
| 2016 | 1.102 |
| 2015 | 1.037 |
| 2014 | 1.069 |
| Year | Ranking |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 3760 |
| 2023 | 4786 |
| 2022 | 4251 |
| 2021 | 3970 |
| 2020 | 3357 |
| 2019 | 3725 |
| 2018 | 3975 |
| 2017 | 4319 |
| 2016 | 3801 |
| 2015 | 4216 |
| 2014 | 3924 |
Expert Review of Neurotherapeutics is published by Taylor and Francis Ltd.. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2001-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Expert Review of Neurotherapeutics is Expert Rev. Neurother.. This abbreviation ('Expert Rev. Neurother.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Neurology (clinical) (Q1); Pharmacology (medical) (Q1); Neuroscience (miscellaneous) (Q2), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Expert Review of Neurotherapeutics latest impact IF is 3.30. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 4.00 (2020) and 2.60 (2015), respectively, in the last 11 years. Moreover, its average IS is 3.29 in the previous 11 years.
The Expert Review of Neurotherapeutics has an SJR (SCImago Journal Rank) of 1.162, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 1.187 in 2020 and the lowest being 0.957 in 2023. Furthermore, the average SJR of the Expert Review of Neurotherapeutics over the previous 11-year period stands at 3.29.
The latest h-index of the Expert Review of Neurotherapeutics is 103.
The Expert Review of Neurotherapeutics is published by the Taylor and Francis Ltd., with its country of publication being the United Kingdom.
The Expert Review of Neurotherapeutics is currently ranked 3760 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 3357 in 2020 and its lowest position of 4786 in 2023.
The standard ISO4 abbreviation for the Expert Review of Neurotherapeutics is Expert Rev. Neurother..
Expert Review of Neurotherapeutics is classified as a journal that the Taylor and Francis Ltd. publishes.
The Expert Review of Neurotherapeutics encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Expert Review of Neurotherapeutics is assigned the following International Standard Serial Numbers (ISSN): 14737175, 17448360.
The best quartile for the Expert Review of Neurotherapeutics is Q1 (2024).
The Expert Review of Neurotherapeutics coverage history can be summarized as follows: 2001-2025.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Journal of Academic Ethics | journal | 8704 | Springer Netherlands | 34 | 4.04 |
| European Union Politics | journal | 1953 | SAGE Publications Ltd | 79 | 3.71 |
| Revue Francophone des Laboratoires (discontinued) | journal | 23244 | Elsevier Masson s.r.l. | 8 | 0.00 |
| IEEE/OSA Journal of Display Technology | journal | 12809 | IEEE Computer Society | 68 | 0.00 |
| Business Strategy Review | journal | 31512 | Wiley-Blackwell Publishing Ltd | 33 | 0.04 |
| Child and Family Social Work | journal | 8793 | Wiley-Blackwell Publishing Ltd | 78 | 2.42 |
| Abacus | journal | 11890 | Wiley-Blackwell Publishing Ltd | 56 | 2.95 |
| Modern Language Journal | journal | 1033 | Wiley-Blackwell | 123 | 3.95 |
| European Surgery - Acta Chirurgica Austriaca | journal | 18136 | Springer Medizin | 25 | 0.68 |
| Asian Textile Journal | trade journal | 25375 | G P S Kwatra | 11 | 0.08 |
| Year | Impact Score (IS) |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 3.30 |
| 2023 | 3.25 |
| 2022 | 3.69 |
| 2021 | 3.61 |
| 2020 | 4.00 |
| 2019 | 3.41 |
| 2018 | 3.08 |
| 2017 | 3.24 |
| 2016 | 3.15 |
| 2015 | 2.60 |
| 2014 | 2.84 |
